| 000 | 01934 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518035754.0 | ||
| 264 | 0 | _c20200214 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1532-2084 | ||
| 024 | 7 |
_a10.1016/j.drup.2019.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaleem, Hamza | |
| 245 | 0 | 0 |
_aThe TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation. _h[electronic resource] |
| 260 |
_bDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy _c03 2019 |
||
| 300 |
_a29-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCarcinogenesis _xdrug effects |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOncogenes _xgenetics |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-met _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-sis _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKulsoom Abdul, U | |
| 700 | 1 | _aKüçükosmanoglu, Asli | |
| 700 | 1 | _aHouweling, Megan | |
| 700 | 1 | _aCornelissen, Fleur M G | |
| 700 | 1 | _aHeiland, Dieter H | |
| 700 | 1 | _aHegi, Monika E | |
| 700 | 1 | _aKouwenhoven, Mathilde C M | |
| 700 | 1 | _aBailey, David | |
| 700 | 1 | _aWürdinger, Tom | |
| 700 | 1 | _aWesterman, Bart A | |
| 773 | 0 |
_tDrug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy _gvol. 43 _gp. 29-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drup.2019.04.002 _zAvailable from publisher's website |
| 999 |
_c29656741 _d29656741 |
||